Developer docs
API playgroundTry for free, no card

Search company profiles

Corewell Health Ventures

Full company profile

uuid000vzk1

Namestring
Corewell Health Ventures
Legal namestring
Corewell Health Ventures
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Corewell Health Ventures is the strategic venture capital arm of Corewell Health, a major integrated health system headquartered in Michigan. Founded in 2017, the firm invests equity capital in healthcare technology companies that have achieved at least $1 million in revenue, are led by experienced management teams, and offer differentiated, well-developed value propositions aligned with the parent's vision of "personalized health, made simple, affordable and exceptional." Corewell Health Ventures explicitly excludes Class III medical devices, pharmaceuticals, biotech, pre-revenue companies, and solutions outside its mission, focusing instead on digital health, clinical workflow, supply chain, and care delivery technologies.

The fund operates a hybrid capital-plus-strategic-partnership model. Portfolio companies receive not only equity but also embedded access to the clinical expertise, operational infrastructure, and commercialization pathways of Corewell Health's integrated delivery network and health plan. The firm complements direct investments with a network of eight strategic co-investment partnerships (7 Wire Ventures, BioStar Capital, Civica, Concord Health Partners, Heritage Group, Lakewood Hughes, New Community Transformation Fund, and The Academy), collectively sourcing deals, sharing diligence, and pooling capital. Other engagement mechanisms include resource-pooling arrangements, de-risking of commercialization, and collaboration agreements. A complementary entity, Corewell Health Innovations, extends engagement beyond equity-only relationships.

The portfolio comprises more than 20 direct investments (AvaSure, Atlas, BedConnect, KeyCare, Leiters, Nudj Health, Peer Supply, ProCredEX, Rad AI, Socially Determined, SpendMend, The Patient Company, TigerConnect, Altus, and others) and approximately 60 indirect investments. Returns are generated through conventional venture capital equity appreciation and exits rather than recurring product or service revenue. The firm is led by Managing Director Christian Rische, supported by Principals Tyler B. Ybema and Kristina Emery, with Maritza Saavedra as Advisor and Cassi Hofmann as Executive Assistant.

Short descriptiontext

Corewell Health Ventures is the strategic venture capital arm of Corewell Health, a Michigan integrated health system. Founded in 2017, the fund invests in revenue-stage healthcare technology companies, offering equity capital alongside the clinical and operational expertise of its parent system.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
Markets served

Serves global market

Keyword5 values
healthcare venture capital, health tech investing, strategic investments, healthcare innovation funding, medical technology equity
Industry2 codes
1Healthcare & Life Sciences Growth Equity
CodeFSANACABPrimaryYes
2Venture Capital Fund-of-Funds
CodeFSANAGACPrimaryNo
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Other Investment Pools and Funds5259
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Venture Capital
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Returns
TypeSubscription Recurring
Description

Corewell Health Ventures generates returns through equity investments in healthcare startups and companies. They invest capital in exchange for ownership stakes and work to drive growth and value for portfolio companies.

corewellhealthventures.org
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Corewell Health Ventures is the strategic venture capital and innovation arm of Corewell Health that invests equity capital in healthcare companies aligned with a vision of personalized, simple, affordable, and exceptional health. The fund targets companies with at least $1M in existing revenue, experienced management teams, and well-developed value propositions, pairing investment capital with the clinical and operational expertise of an integrated health system and health plan.

Differentiator
Functional benefit
Problem solved
Product and service4 records
1Direct Healthcare Equity Investments
CategoryVenture Capital Investment
2Strategic Healthcare Partnerships
CategoryStrategic Partnership
3Indirect Healthcare Fund Investments
CategoryFund-of-Funds Investment
4Healthcare Commercialization Collaboration Agreements
CategoryCommercialization Services
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

An early stage, health care venture fund that helps entrepreneurs who focus on empowering the Informed Connected Health Consumer to change the status quo.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

BioStar focuses on making impactful and transformational investments in medical technologies including devices, digital health, robotics, and diagnostics with an emphasis on cardiovascular and orthopedics.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Civica's mission is to provide quality generic medicines that are available and affordable to everyone.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Concord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through products, services, technologies and solutions that lower costs, improve quality and/or expand access to care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic investors that help identify and build solutions for unique challenges, working closely with management teams and Portfolio Companies to drive growth.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

An investment firm of the Buzzitta Family Office that provides capital and operational support to companies in the industrial, technology and health care sectors.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

This fund supports both founders of color willing to move their enterprise to West Michigan as well as West Michigan-based companies that have founders or entrepreneurs of color.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Strategic Partnership Alliance was established by the Health Management Academy to drive the due diligence of de novo partnership opportunities across a collaborative of health systems.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The strategic corporate venture arm of Kaiser Permanente, one of the largest integrated US health systems. Directly comparable to Corewell Health Ventures in mission, structure (health system LP), and value proposition (clinical validation + capital for healthcare startups).

TypeDirect peer
Description

Strategic healthcare investors that work closely with management teams and portfolio companies to drive growth. Listed as a Corewell strategic partner and a directly comparable healthcare-focused strategic investor.

TypeDirect peer
Description

The innovation and venture arm of UPMC, a large integrated payer-provider health system. Operates a similar model of investing in healthcare technology with the backing of an integrated delivery network — closely aligned with Corewell's structure.

TypeDirect peer
Description

Venture arm of Mass General Brigham, an academic integrated health system. Comparable as a health-system-backed strategic investor focused on commercial-stage healthcare innovation with clinical-validation advantages.

TypeBroad incumbent
Description

The venture arm of Optum (UnitedHealth Group), a much larger and better-capitalized healthcare strategic investor. Competes for the same healthcare-innovation deal flow and serves as a benchmark for what scaled strategic healthcare VC looks like.

TypeDirect peer
Description

An early-stage healthcare venture fund focused on the Informed Connected Health Consumer. Listed as a Corewell strategic partner and a direct peer in healthcare-focused venture investing with a consumer-health orientation.

TypeDirect peer
Description

A venture fund investing in medical technologies, devices, digital health, robotics, and diagnostics. Listed as a Corewell strategic partner and directly comparable as a healthcare-focused VC with overlapping investment categories.

TypeDirect peer
Description

The venture arm of OSF HealthCare, an integrated health system. Closely mirrors Corewell's model of providing capital plus clinical and operational expertise to healthcare startups.

TypeDirect peer
Description

Strategic venture capital arm of Ascension Health, one of the largest US non-profit health systems. Direct peer in the health-system LP category with a comparable focus on healthcare innovation investments.

TypeDirect peer
Description

A healthcare-focused private equity firm that partners with health systems to invest in companies lowering cost, improving quality, and expanding access to care. Listed as a Corewell strategic partner and directly comparable as a strategic healthcare investor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Corewell Health Ventures

Healthcare Venture Capitalcorewellhealthventures.org

Corewell Health Ventures is the strategic venture capital arm of Corewell Health, a Michigan integrated health system. Founded in 2017, the fund invests in revenue-stage healthcare technology companies, offering equity capital alongside the clinical and operational expertise of its parent system.

What Corewell Health Ventures does

Corewell Health Ventures is the strategic venture capital arm of Corewell Health, a major integrated health system headquartered in Michigan. Founded in 2017, the firm invests equity capital in healthcare technology companies that have achieved at least $1 million in revenue, are led by experienced management teams, and offer differentiated, well-developed value propositions aligned with the parent's vision of "personalized health, made simple, affordable and exceptional." Corewell Health Ventures explicitly excludes Class III medical devices, pharmaceuticals, biotech, pre-revenue companies, and solutions outside its mission, focusing instead on digital health, clinical workflow, supply chain, and care delivery technologies.

The fund operates a hybrid capital-plus-strategic-partnership model. Portfolio companies receive not only equity but also embedded access to the clinical expertise, operational infrastructure, and commercialization pathways of Corewell Health's integrated delivery network and health plan. The firm complements direct investments with a network of eight strategic co-investment partnerships (7 Wire Ventures, BioStar Capital, Civica, Concord Health Partners, Heritage Group, Lakewood Hughes, New Community Transformation Fund, and The Academy), collectively sourcing deals, sharing diligence, and pooling capital. Other engagement mechanisms include resource-pooling arrangements, de-risking of commercialization, and collaboration agreements. A complementary entity, Corewell Health Innovations, extends engagement beyond equity-only relationships.

The portfolio comprises more than 20 direct investments (AvaSure, Atlas, BedConnect, KeyCare, Leiters, Nudj Health, Peer Supply, ProCredEX, Rad AI, Socially Determined, SpendMend, The Patient Company, TigerConnect, Altus, and others) and approximately 60 indirect investments. Returns are generated through conventional venture capital equity appreciation and exits rather than recurring product or service revenue. The firm is led by Managing Director Christian Rische, supported by Principals Tyler B. Ybema and Kristina Emery, with Maritza Saavedra as Advisor and Cassi Hofmann as Executive Assistant.

Corewell Health Ventures firmographics

Firmographics
Name
Corewell Health Ventures
Legal name
Corewell Health Ventures
Website
https://corewellhealthventures.org
Company type
Private
Founded year
2017
Operating status
Operating
Short description
Corewell Health Ventures is the strategic venture capital arm of Corewell Health, a Michigan integrated health system. Founded in 2017, the fund invests in revenue-stage healthcare technology companies, offering equity capital alongside the clinical and operational expertise of its parent system.
Ownership category
akta.pro rank

Corewell Health Ventures industry classification

Industry
Product category
Healthcare Venture Capital
NAICS
Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)
SIC
Investment Advice (6282)
akta.pro primary industry
Healthcare & Life Sciences Growth Equity (FSANACAB)
akta.pro secondary industry
Venture Capital Fund-of-Funds (FSANAGAC)

Keywords

  • Healthcare venture capital
  • Health tech investing
  • Strategic investments
  • Healthcare innovation funding
  • Medical technology equity

Corewell Health Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

Revenue model

  1. Venture Capital Returns: Corewell Health Ventures generates returns through equity investments in healthcare startups and companies. They invest capital in exchange for ownership stakes and work to drive growth and value for portfolio companies.

Go-to-market motion1 record

Marketing channels1 record

Corewell Health Ventures product offering

Product offering

Core offering

Corewell Health Ventures is the strategic venture capital and innovation arm of Corewell Health that invests equity capital in healthcare companies aligned with a vision of personalized, simple, affordable, and exceptional health. The fund targets companies with at least $1M in existing revenue, experienced management teams, and well-developed value propositions, pairing investment capital with the clinical and operational expertise of an integrated health system and health plan.

Differentiator

Problem solved

Functional benefit

Products and services

  • Direct Healthcare Equity Investments
  • Strategic Healthcare Partnerships
  • Indirect Healthcare Fund Investments
  • Healthcare Commercialization Collaboration Agreements

Companies that use Corewell Health Ventures

Customer profile

Segments1 record

Ideal customer profiles1 record

Corewell Health Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Corewell Health Ventures partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • 7 Wire VenturescoreStrategic or Co-development PartnerAn early stage, health care venture fund that helps entrepreneurs who focus on empowering the Informed Connected Health Consumer to change the status quo.
  • BioStar CapitalcoreStrategic or Co-development PartnerBioStar focuses on making impactful and transformational investments in medical technologies including devices, digital health, robotics, and diagnostics with an emphasis on cardiovascular and orthopedics.
  • CivicacoreStrategic or Co-development PartnerCivica's mission is to provide quality generic medicines that are available and affordable to everyone.
  • Concord Health PartnerscoreStrategic or Co-development PartnerConcord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through products, services, technologies and solutions that lower costs, improve quality and/or expand access to care.
  • Heritage GroupcoreStrategic or Co-development PartnerStrategic investors that help identify and build solutions for unique challenges, working closely with management teams and Portfolio Companies to drive growth.
  • Lakewood HughesminorStrategic or Co-development PartnerAn investment firm of the Buzzitta Family Office that provides capital and operational support to companies in the industrial, technology and health care sectors.
  • New Community Transformation FundminorStrategic or Co-development PartnerThis fund supports both founders of color willing to move their enterprise to West Michigan as well as West Michigan-based companies that have founders or entrepreneurs of color.
  • The Academy (Health Management Academy)coreStrategic or Co-development PartnerThe Strategic Partnership Alliance was established by the Health Management Academy to drive the due diligence of de novo partnership opportunities across a collaborative of health systems.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Corewell Health Ventures competitors and assessment

Company assessment

Direct peers

  • Kaiser Permanente Ventures: The strategic corporate venture arm of Kaiser Permanente, one of the largest integrated US health systems. Directly comparable to Corewell Health Ventures in mission, structure (health system LP), and value proposition (clinical validation + capital for healthcare startups).
  • Heritage Group: Strategic healthcare investors that work closely with management teams and portfolio companies to drive growth. Listed as a Corewell strategic partner and a directly comparable healthcare-focused strategic investor.
  • UPMC Enterprises: The innovation and venture arm of UPMC, a large integrated payer-provider health system. Operates a similar model of investing in healthcare technology with the backing of an integrated delivery network — closely aligned with Corewell's structure.
  • Mass General Brigham Ventures: Venture arm of Mass General Brigham, an academic integrated health system. Comparable as a health-system-backed strategic investor focused on commercial-stage healthcare innovation with clinical-validation advantages.
  • 7 Wire Ventures: An early-stage healthcare venture fund focused on the Informed Connected Health Consumer. Listed as a Corewell strategic partner and a direct peer in healthcare-focused venture investing with a consumer-health orientation.
  • BioStar Capital: A venture fund investing in medical technologies, devices, digital health, robotics, and diagnostics. Listed as a Corewell strategic partner and directly comparable as a healthcare-focused VC with overlapping investment categories.
  • OSF Ventures: The venture arm of OSF HealthCare, an integrated health system. Closely mirrors Corewell's model of providing capital plus clinical and operational expertise to healthcare startups.
  • Ascension Ventures: Strategic venture capital arm of Ascension Health, one of the largest US non-profit health systems. Direct peer in the health-system LP category with a comparable focus on healthcare innovation investments.
  • Concord Health Partners: A healthcare-focused private equity firm that partners with health systems to invest in companies lowering cost, improving quality, and expanding access to care. Listed as a Corewell strategic partner and directly comparable as a strategic healthcare investor.

Broad incumbents

  • Optum Ventures: The venture arm of Optum (UnitedHealth Group), a much larger and better-capitalized healthcare strategic investor. Competes for the same healthcare-innovation deal flow and serves as a benchmark for what scaled strategic healthcare VC looks like.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Corewell Health Ventures social profiles

Digital presence

Corewell Health Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Corewell Health Ventures leadership team

Management profile

Number of profiles

Profiles5 records

Corewell Health Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Corewell Health Ventures M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Corewell Health Ventures

What does Corewell Health Ventures do?

Corewell Health Ventures is the strategic venture capital and innovation arm of Corewell Health that invests equity capital in healthcare companies aligned with a vision of personalized, simple, affordable, and exceptional health. The fund targets companies with at least $1M in existing revenue, experienced management teams, and well-developed value propositions, pairing investment capital with the clinical and operational expertise of an integrated health system and health plan.

Is Corewell Health Ventures a public or private company?

Corewell Health Ventures is a private company. It is classified as corporate owned and is currently operating.

When was Corewell Health Ventures founded?

Corewell Health Ventures was founded in 2017.

How does Corewell Health Ventures make money?

One revenue line is on record: venture Capital Returns.

Who are Corewell Health Ventures's main competitors?

Direct peers on record are Kaiser Permanente Ventures, Heritage Group, UPMC Enterprises, Mass General Brigham Ventures, 7 Wire Ventures, BioStar Capital, OSF Ventures, Ascension Ventures and Concord Health Partners. Optum Ventures is listed as a broad incumbent.

Does Corewell Health Ventures have an API?

No public API is recorded for Corewell Health Ventures.

What industry is Corewell Health Ventures in?

Corewell Health Ventures's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of FSANAGAC, Venture Capital Fund-of-Funds. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketScaleAI agents for patient care draw $335 million in a single month as health tech investment acceleratesIn June 2026, four health tech companies—Assort Health, Cadence, Adaptive Innovations, and Stepful—collectively raised $335 million in funding, with AI agent platforms for patient scheduling, chronic disease management, home health logistics, and healthcare worker training dominating the investment rounds. The participation of health system investors including Corewell Health Ventures, Memorial Hermann, and Duke Health in Cadence's $100 million Series C signals operational conviction beyond financial speculation, as these providers are investing in their own vendor's technology. The concentration of capital across multiple operational bottlenecks in care delivery reflects a clear shift among health system operators from evaluating AI tools to deploying them at scale.The SaaS NewsCadence Raises $100M Series CCadence, a clinical AI company based in New York, announced a $100 million Series C funding round led by Spark Capital, with participation from Thrive Capital, General Catalyst, Coatue, B Capital, Corewell Health Ventures, Memorial Hermann, and Duke Health. The company, which automates chronic care management for older adults, has deployed its platform across more than 20 leading health systems and plans to use the capital to expand operations and advance its clinical AI agents. The funding addresses the growing clinician shortage in the United States while supporting growth in value-based care models.FierceHealthcareCadence secures $100M series C to advance AI-powered care for chronic diseaseHealth tech startup Cadence secured $100 million in Series C funding led by Spark Capital, with participation from Thrive Capital, General Catalyst, Coatue, B Capital, Corewell Health Ventures, Memorial Hermann and Duke Health. The company plans to use the capital to advance its AI agents for chronic disease management, grow its value-based care models and expand into new health systems. Cadence currently treats over 100,000 patients across more than 20 health systems, tripled its annual recurring revenue in 2025, and announced new affiliations with Duke Health and Texas Health Resources alongside the funding.Venture Capital Access OnlineCadence Raises $100M Series C Led by Spark Capital to Automate Chronic CareCadence, a clinical AI company, raised $100 million in a Series C led by Spark Capital. The funding will scale AI agents to serve over 56 million older adults with chronic disease, and the company now treats over 100,000 patients across 20+ health systems.